Biologics R&D: select news

ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosis

https://pubmed.ncbi.nlm.nih.gov/40467521/

jeanfrancoismaison

Jun 51 min read

Targeting CD117 on hematopoietic stem and progenitor cells impairs CAR T cell activity

https://pubmed.ncbi.nlm.nih.gov/40450523/

jeanfrancoismaison

Jun 51 min read

MDM2 inhibitors in sarcomas: results and next steps

https://pubmed.ncbi.nlm.nih.gov/40464483/

jeanfrancoismaison

Jun 51 min read

Optimization of a novel 2+2 BCMA x CD3 bispecific antibody for minimized cytokine release and potent efficacy

https://pubmed.ncbi.nlm.nih.gov/40465538/

jeanfrancoismaison

Jun 51 min read

Phase I/II Study of Subasumstat (TAK-981) in Combination With Rituximab in Relapsed/Refractory Non-Hodgkin Lymphoma

https://pubmed.ncbi.nlm.nih.gov/40467383/

jeanfrancoismaison

Jun 51 min read

Antibody-drug conjugates in cancer therapy: applications and future advances

https://pubmed.ncbi.nlm.nih.gov/40469310/

jeanfrancoismaison

Jun 51 min read

Advanced Quantification Pipeline Reveals New Spatial and Temporal Tumor Characteristics in Preclinical Multiple Myeloma

https://pubmed.ncbi.nlm.nih.gov/40470226/

jeanfrancoismaison

Jun 51 min read

Glucocorticoid Dosing and Implications for Vaccination: Evolution of Global Definitions

https://pubmed.ncbi.nlm.nih.gov/39692483/

jeanfrancoismaison

Jun 51 min read

Ongoing Symptoms After Acute SARS-CoV-2 or Influenza Infection in a Case-Ascertained Household Transmission Study: 7 US Sites, 2021-2023

https://pubmed.ncbi.nlm.nih.gov/40036243/

jeanfrancoismaison

Jun 51 min read

DNA co-delivery of seasonal H1 influenza hemagglutinin nanoparticle vaccines with chemokine adjuvant CTACK induces potent immunogenicity for heterologous protection in vivo

https://pubmed.ncbi.nlm.nih.gov/40398322/

jeanfrancoismaison

Jun 51 min read

Immunogenicity and adverse effects of pneumococcal vaccines co-administered with influenza or SARS-CoV-2 vaccines in adults: A systematic review and Meta-analysis

https://pubmed.ncbi.nlm.nih.gov/40412334/

jeanfrancoismaison

Jun 51 min read

Assay for rapid quantification of capped and tailed intact mRNA

https://pubmed.ncbi.nlm.nih.gov/40466481/

jeanfrancoismaison

Jun 51 min read

Methods integrating innate and adaptive immune responses in human in vitro immunization assays

https://pubmed.ncbi.nlm.nih.gov/40469296/

jeanfrancoismaison

Jun 51 min read

Discovery of novel and selective GPR17 antagonists as pharmacological tools for developing new therapeutic strategies in diabetes and obesity

https://pubmed.ncbi.nlm.nih.gov/40460721/

jeanfrancoismaison

Jun 41 min read

Risk of COVID-19 reinfection and vaccine breakthrough infection, Madera County, California, 2021

https://pubmed.ncbi.nlm.nih.gov/39191647/

jeanfrancoismaison

Jun 41 min read

Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections

https://pubmed.ncbi.nlm.nih.gov/40425779/

jeanfrancoismaison

Jun 41 min read

The Current Landscape for Human Papillomavirus Vaccination in Oropharyngeal Carcinoma

https://pubmed.ncbi.nlm.nih.gov/40459980/

jeanfrancoismaison

Jun 41 min read

Reverse vaccinology for hookworms: a rational selection of vaccinable antigens against parasitic nematodes

https://pubmed.ncbi.nlm.nih.gov/40460272/

jeanfrancoismaison

Jun 41 min read

Reverse vaccinology for hookworms: a rational selection of vaccinable antigens against parasitic nematodes

https://pubmed.ncbi.nlm.nih.gov/40460272/

jeanfrancoismaison

Jun 41 min read

Post-mortem study of endemic human coronaviruses (HCoV-NL63, OC43, 229E and HKU-1) in deaths of children under five in low- and middle-income countries: Findings from the Child Health and Mortality Pr

https://pubmed.ncbi.nlm.nih.gov/40460588/

jeanfrancoismaison

Jun 41 min read